|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 25/28 |
| (11) | Number of the document | 2996772 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14798473.6 |
| Date of filing the European patent application | 2014-05-13 | |
| (97) | Date of publication of the European application | 2016-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/037761 |
| Date | 2014-05-13 |
| (87) | Number | WO 2014/186310 |
| Date | 2014-11-20 |
| (30) | Number | Date | Country code |
| 201361822795 P | 2013-05-13 | US |
| (72) |
PROD`HOMME, Thomas, E., US
LING, Leona, E., US
BOSQUES, Carlos, J., US
MANNING, Anthony, US
KAUNDINYA, Ganesh, US
|
| (73) |
Momenta Pharmaceuticals, Inc.,
301 Binney Street, Cambridge, MA 02142,
US
|
| (54) | METHODS FOR THE TREATMENT OF NEURODEGENERATION |
| METHODS FOR THE TREATMENT OF NEURODEGENERATION |